Clinical Trial Update: Safety and Efficacy Study of KAI-1678 to Treat Subjects With Postoperative Pain [Phase 2]

View source ↗

Summary

Phase 2 trial results for KAI-1678 in postoperative pain have been completed, reporting safety and efficacy findings.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Pain

Drugs mentioned

• KAI-1678

Snippet

Sponsor: KAI Pharmaceuticals | Conditions: Pain, Postoperative | Phase 2 | Status: COMPLETED